Quotient Sciences Header

Quotient Sciences Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

Taiba Healthcare

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Elevar Therapeutics and Taiba Middle East FZ LLC Partner to Commercialize Apealea® in the Middle East and North Africa Region

Details:

Tiba will be responsible for managing named-patient requests through which physicians can legally and ethically prescribe Apealea for patients prior to commercial availability, commercialize and distribute the product throughout the Middle East and North African region.

Lead Product(s): Paclitaxel,Carboplatin

Therapeutic Area: Oncology Product Name: Apealea

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Elevar Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement October 05, 2020

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY